10-Q Filing

ABBVIE INC. CIK: 1551152 Q2 2023

Filing Information

Form Type	10-Q
Accession Number	`0001551152-23-000033`
Period End Date	20230630
Filing Date	20230807
Fiscal Year	2023
Fiscal Period	Q2
XBRL Instance	abbv-20230630_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 70 Income Statement 80 Cash Flow Statement 81 Stockholders Equity 36 Comprehensive Income 52

Balance Sheet 70 line items

Line Item	Tag	Value	Unit	Period
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Common stock, authorized (in shares)	`CommonStockSharesAuthorized`	4.00B	shares	Point-in-time
Common stock, authorized (in shares)	`CommonStockSharesAuthorized`	4.00B	shares	Point-in-time
Cash and equivalents	`CashAndCashEquivalentsAtCarryingValue`	$9.20B	USD	Point-in-time
Cash and equivalents	`CashAndCashEquivalentsAtCarryingValue`	$8.76B	USD	Point-in-time
Common stock, issued (in shares)	`CommonStockSharesIssued`	1.82B	shares	Point-in-time
Common stock, issued (in shares)	`CommonStockSharesIssued`	1.81B	shares	Point-in-time
Short-term investments	`ShortTermInvestments`	$7.00M	USD	Point-in-time
Treasury Stock, Common, Shares	`TreasuryStockCommonShares`	44.59M	shares	Point-in-time
Treasury Stock, Common, Shares	`TreasuryStockCommonShares`	57.13M	shares	Point-in-time
Short-term investments	`ShortTermInvestments`	$28.00M	USD	Point-in-time
Accounts receivable, net	`AccountsReceivableNetCurrent`	$11.49B	USD	Point-in-time
Accounts receivable, net	`AccountsReceivableNetCurrent`	$11.25B	USD	Point-in-time
Inventories	`InventoryNet`	$3.58B	USD	Point-in-time
Inventories	`InventoryNet`	$4.05B	USD	Point-in-time
Prepaid expenses and other	`PrepaidExpenseAndOtherAssets`	$4.54B	USD	Point-in-time
Prepaid expenses and other	`PrepaidExpenseAndOtherAssets`	$4.40B	USD	Point-in-time
Total current assets	`AssetsCurrent`	$28.46B	USD	Point-in-time
Total current assets	`AssetsCurrent`	$28.85B	USD	Point-in-time
Investments	`LongTermInvestments`	$288.00M	USD	Point-in-time
Investments	`LongTermInvestments`	$241.00M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$4.93B	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$4.94B	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$62.86B	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$67.44B	USD	Point-in-time
Goodwill	`Goodwill`	$32.22B	USD	Point-in-time
Goodwill	`Goodwill`	$32.16B	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$6.20B	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$5.57B	USD	Point-in-time
Total assets	`Assets`	$138.81B	USD	Point-in-time
Total assets	`Assets`	$135.37B	USD	Point-in-time
Short-term borrowings	`ShortTermBorrowings`	$1.00M	USD	Point-in-time
Short-term borrowings	`ShortTermBorrowings`	-	USD	Point-in-time
Current portion of long-term debt and finance lease obligations	`LongTermDebtAndCapitalLeaseObligationsCurrent`	$5.20B	USD	Point-in-time
Current portion of long-term debt and finance lease obligations	`LongTermDebtAndCapitalLeaseObligationsCurrent`	$4.13B	USD	Point-in-time
Accounts payable and accrued liabilities	`AccountsPayableAndAccruedLiabilitiesCurrent`	$27.04B	USD	Point-in-time
Accounts payable and accrued liabilities	`AccountsPayableAndAccruedLiabilitiesCurrent`	$25.40B	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$29.54B	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$32.24B	USD	Point-in-time
Long-term debt and finance lease obligations	`LongTermDebtAndCapitalLeaseObligations`	$59.13B	USD	Point-in-time
Long-term debt and finance lease obligations	`LongTermDebtAndCapitalLeaseObligations`	$55.81B	USD	Point-in-time
Deferred income taxes	`DeferredIncomeTaxLiabilitiesNet`	$2.19B	USD	Point-in-time
Deferred income taxes	`DeferredIncomeTaxLiabilitiesNet`	$2.12B	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$30.66B	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$32.29B	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Common stock, $0.01 par value, 4,000,000,000 shares authorized, 1,821,926,709 shares issued as of June 30, 2023 and 1,813,770,294 as of December 31, 2022	`CommonStockValueOutstanding`	$18.00M	USD	Point-in-time
Common stock, $0.01 par value, 4,000,000,000 shares authorized, 1,821,926,709 shares issued as of June 30, 2023 and 1,813,770,294 as of December 31, 2022	`CommonStockValueOutstanding`	$18.00M	USD	Point-in-time
Common stock held in treasury, at cost, 57,127,750 shares as of June 30, 2023 and 44,589,000 as of December 31, 2022	`TreasuryStockValue`	$4.59B	USD	Point-in-time
Common stock held in treasury, at cost, 57,127,750 shares as of June 30, 2023 and 44,589,000 as of December 31, 2022	`TreasuryStockValue`	$6.53B	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$19.25B	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$19.84B	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$1.79B	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$4.78B	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-2.25B	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-2.20B	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$17.25B	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$12.87B	USD	Point-in-time
Noncontrolling interest	`MinorityInterest`	$32.00M	USD	Point-in-time
Noncontrolling interest	`MinorityInterest`	$33.00M	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$15.44B	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$16.31B	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$12.90B	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$13.30B	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$14.69B	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$17.29B	USD	Point-in-time
Total liabilities and equity	`LiabilitiesAndStockholdersEquity`	$135.37B	USD	Point-in-time
Total liabilities and equity	`LiabilitiesAndStockholdersEquity`	$138.81B	USD	Point-in-time

Income Statement 80 line items

Line Item	Tag	Value	Unit	Period
Net revenues	`Revenues`	$13.87B	USD	1 Quarter
Net revenues	`Revenues`	$28.12B	USD	2 Qtrs
Net revenues	`Revenues`	$14.58B	USD	1 Quarter
Net revenues	`Revenues`	$26.09B	USD	2 Qtrs
Cost of products sold	`CostOfGoodsAndServicesSold`	$8.23B	USD	2 Qtrs
Cost of products sold	`CostOfGoodsAndServicesSold`	$8.22B	USD	2 Qtrs
Cost of products sold	`CostOfGoodsAndServicesSold`	$4.24B	USD	1 Quarter
Cost of products sold	`CostOfGoodsAndServicesSold`	$4.17B	USD	1 Quarter
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$8.54B	USD	2 Qtrs
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$6.31B	USD	2 Qtrs
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$5.41B	USD	1 Quarter
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$3.27B	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost`	$1.73B	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost`	$1.61B	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost`	$4.03B	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost`	$3.11B	USD	2 Qtrs
Acquired IPR&D and milestones	`ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff`	$280.00M	USD	1 Quarter
Acquired IPR&D and milestones	`ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff`	$430.00M	USD	2 Qtrs
Acquired IPR&D and milestones	`ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff`	$414.00M	USD	2 Qtrs
Acquired IPR&D and milestones	`ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff`	$269.00M	USD	1 Quarter
Other operating income	`OtherOperatingIncomeExpenseNet`	$172.00M	USD	1 Quarter
Other operating income	`OtherOperatingIncomeExpenseNet`	$179.00M	USD	2 Qtrs
Other operating income	`OtherOperatingIncomeExpenseNet`	$169.00M	USD	1 Quarter
Other operating income	`OtherOperatingIncomeExpenseNet`	$172.00M	USD	2 Qtrs
Total operating costs and expenses	`CostsAndExpenses`	$11.29B	USD	1 Quarter
Total operating costs and expenses	`CostsAndExpenses`	$20.11B	USD	2 Qtrs
Total operating costs and expenses	`CostsAndExpenses`	$9.35B	USD	1 Quarter
Total operating costs and expenses	`CostsAndExpenses`	$18.81B	USD	2 Qtrs
Operating earnings	`OperatingIncomeLoss`	$3.29B	USD	1 Quarter
Operating earnings	`OperatingIncomeLoss`	$4.51B	USD	1 Quarter
Operating earnings	`OperatingIncomeLoss`	$7.28B	USD	2 Qtrs
Operating earnings	`OperatingIncomeLoss`	$8.01B	USD	2 Qtrs
Interest expense, net	`InterestIncomeExpenseNonoperatingNet`	$-454.00M	USD	1 Quarter
Interest expense, net	`InterestIncomeExpenseNonoperatingNet`	$-908.00M	USD	2 Qtrs
Interest expense, net	`InterestIncomeExpenseNonoperatingNet`	$-1.07B	USD	2 Qtrs
Interest expense, net	`InterestIncomeExpenseNonoperatingNet`	$-532.00M	USD	1 Quarter
Net foreign exchange loss	`ForeignCurrencyTransactionGainLossBeforeTax`	$-72.00M	USD	2 Qtrs
Net foreign exchange loss	`ForeignCurrencyTransactionGainLossBeforeTax`	$-72.00M	USD	2 Qtrs
Net foreign exchange loss	`ForeignCurrencyTransactionGainLossBeforeTax`	$-47.00M	USD	1 Quarter
Net foreign exchange loss	`ForeignCurrencyTransactionGainLossBeforeTax`	$-37.00M	USD	1 Quarter
Other expense, net	`OtherNonoperatingIncomeExpense`	$-1.41B	USD	1 Quarter
Other expense, net	`OtherNonoperatingIncomeExpense`	$-1.53B	USD	1 Quarter
Other expense, net	`OtherNonoperatingIncomeExpense`	$-757.00M	USD	2 Qtrs
Other expense, net	`OtherNonoperatingIncomeExpense`	$-3.22B	USD	2 Qtrs
Earnings before income tax expense	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$6.11B	USD	2 Qtrs
Earnings before income tax expense	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$3.08B	USD	2 Qtrs
Earnings before income tax expense	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$2.61B	USD	1 Quarter
Earnings before income tax expense	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$1.18B	USD	1 Quarter
Income tax expense	`IncomeTaxExpenseBenefit`	$817.00M	USD	2 Qtrs
Income tax expense	`IncomeTaxExpenseBenefit`	$255.00M	USD	1 Quarter
Income tax expense	`IncomeTaxExpenseBenefit`	$691.00M	USD	2 Qtrs
Income tax expense	`IncomeTaxExpenseBenefit`	$583.00M	USD	1 Quarter
Net earnings	`ProfitLoss`	$5.42B	USD	2 Qtrs
Net earnings	`ProfitLoss`	$2.27B	USD	2 Qtrs
Net earnings	`ProfitLoss`	$928.00M	USD	1 Quarter
Net earnings	`ProfitLoss`	$2.03B	USD	1 Quarter
Net earnings attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$7.00M	USD	2 Qtrs
Net earnings attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$4.00M	USD	1 Quarter
Net earnings attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$5.00M	USD	2 Qtrs
Net earnings attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$3.00M	USD	1 Quarter
Net earnings attributable to AbbVie Inc.	`NetIncomeLoss`	$2.26B	USD	2 Qtrs
Net earnings attributable to AbbVie Inc.	`NetIncomeLoss`	$5.41B	USD	2 Qtrs
Net earnings attributable to AbbVie Inc.	`NetIncomeLoss`	$924.00M	USD	1 Quarter
Net earnings attributable to AbbVie Inc.	`NetIncomeLoss`	$2.02B	USD	1 Quarter
Basic earnings per share (in dollars per share)	`EarningsPerShareBasic`	$0.52	USD	1 Quarter
Basic earnings per share (in dollars per share)	`EarningsPerShareBasic`	$1.27	USD	2 Qtrs
Basic earnings per share (in dollars per share)	`EarningsPerShareBasic`	$1.14	USD	1 Quarter
Basic earnings per share (in dollars per share)	`EarningsPerShareBasic`	$3.04	USD	2 Qtrs
Diluted earnings per share (in dollars per share)	`EarningsPerShareDiluted`	$0.51	USD	1 Quarter
Diluted earnings per share (in dollars per share)	`EarningsPerShareDiluted`	$1.26	USD	2 Qtrs
Diluted earnings per share (in dollars per share)	`EarningsPerShareDiluted`	$3.03	USD	2 Qtrs
Diluted earnings per share (in dollars per share)	`EarningsPerShareDiluted`	$1.14	USD	1 Quarter
Weighted-average basic shares outstanding (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	1.77B	shares	1 Quarter
Weighted-average basic shares outstanding (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	1.77B	shares	2 Qtrs
Weighted-average basic shares outstanding (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	1.77B	shares	2 Qtrs
Weighted-average basic shares outstanding (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	1.77B	shares	1 Quarter
Weighted-average diluted shares outstanding (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	1.77B	shares	2 Qtrs
Weighted-average diluted shares outstanding (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	1.78B	shares	2 Qtrs
Weighted-average diluted shares outstanding (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	1.77B	shares	1 Quarter
Weighted-average diluted shares outstanding (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	1.78B	shares	1 Quarter

Cash Flow Statement 81 line items

Line Item	Tag	Value	Unit	Period
Net earnings	`ProfitLoss`	$5.42B	USD	2 Qtrs
Net earnings	`ProfitLoss`	$2.27B	USD	2 Qtrs
Net earnings	`ProfitLoss`	$928.00M	USD	1 Quarter
Net earnings	`ProfitLoss`	$2.03B	USD	1 Quarter
Depreciation	`Depreciation`	$401.00M	USD	2 Qtrs
Depreciation	`Depreciation`	$190.00M	USD	1 Quarter
Depreciation	`Depreciation`	$369.00M	USD	2 Qtrs
Depreciation	`Depreciation`	$203.00M	USD	1 Quarter
Amortization of intangible assets	`AmortizationOfIntangibleAssets`	$4.02B	USD	2 Qtrs
Amortization of intangible assets	`AmortizationOfIntangibleAssets`	$3.70B	USD	2 Qtrs
Amortization of intangible assets	`AmortizationOfIntangibleAssets`	$2.10B	USD	1 Quarter
Amortization of intangible assets	`AmortizationOfIntangibleAssets`	$1.80B	USD	1 Quarter
Deferred income taxes	`DeferredIncomeTaxExpenseBenefit`	$-794.00M	USD	2 Qtrs
Deferred income taxes	`DeferredIncomeTaxExpenseBenefit`	$-635.00M	USD	2 Qtrs
Change in fair value of contingent consideration liabilities	`BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1`	$861.00M	USD	2 Qtrs
Change in fair value of contingent consideration liabilities	`BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1`	$3.42B	USD	2 Qtrs
Stock-based compensation	`ShareBasedCompensation`	$413.00M	USD	2 Qtrs
Stock-based compensation	`ShareBasedCompensation`	$492.00M	USD	2 Qtrs
Acquired IPR&D and milestones	`ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff`	$280.00M	USD	1 Quarter
Acquired IPR&D and milestones	`ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff`	$430.00M	USD	2 Qtrs
Acquired IPR&D and milestones	`ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff`	$414.00M	USD	2 Qtrs
Acquired IPR&D and milestones	`ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff`	$269.00M	USD	1 Quarter
Gain on divestitures	`GainLossOnSaleOfOtherAssets`	$172.00M	USD	2 Qtrs
Non-cash litigation reserve adjustments, net of cash payments	`NonCashLitigationReserveAdjustmentsNetOfCashPayments`	$-118.00M	USD	2 Qtrs
Non-cash litigation reserve adjustments, net of cash payments	`NonCashLitigationReserveAdjustmentsNetOfCashPayments`	$2.19B	USD	2 Qtrs
Impairment of intangible assets	`ImpairmentOfIntangibleAssetsExcludingGoodwill`	-	USD	2 Qtrs
Impairment of intangible assets	`ImpairmentOfIntangibleAssetsExcludingGoodwill`	$710.00M	USD	2 Qtrs
Other, net	`OtherNoncashIncomeExpense`	$86.00M	USD	2 Qtrs
Other, net	`OtherNoncashIncomeExpense`	$173.00M	USD	2 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$275.00M	USD	2 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$1.40B	USD	2 Qtrs
Inventories	`IncreaseDecreaseInInventories`	$458.00M	USD	2 Qtrs
Inventories	`IncreaseDecreaseInInventories`	$499.00M	USD	2 Qtrs
Prepaid expenses and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-14.00M	USD	2 Qtrs
Prepaid expenses and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-285.00M	USD	2 Qtrs
Accounts payable and other liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$1.11B	USD	2 Qtrs
Accounts payable and other liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-448.00M	USD	2 Qtrs
Income tax assets and liabilities, net	`IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable`	$-932.00M	USD	2 Qtrs
Income tax assets and liabilities, net	`IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable`	$-110.00M	USD	2 Qtrs
Cash flows from operating activities	`NetCashProvidedByUsedInOperatingActivities`	$9.91B	USD	2 Qtrs
Cash flows from operating activities	`NetCashProvidedByUsedInOperatingActivities`	$10.51B	USD	2 Qtrs
Acquisitions and investments	`PaymentsToAcquireOtherInvestments`	$394.00M	USD	2 Qtrs
Acquisitions and investments	`PaymentsToAcquireOtherInvestments`	$513.00M	USD	2 Qtrs
Acquisitions of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$305.00M	USD	2 Qtrs
Acquisitions of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$353.00M	USD	2 Qtrs
Purchases of investment securities	`PaymentsToAcquireMarketableSecurities`	$1.41B	USD	2 Qtrs
Purchases of investment securities	`PaymentsToAcquireMarketableSecurities`	$35.00M	USD	2 Qtrs
Sales and maturities of investment securities	`ProceedsFromSaleMaturityAndCollectionsOfInvestments`	$36.00M	USD	2 Qtrs
Sales and maturities of investment securities	`ProceedsFromSaleMaturityAndCollectionsOfInvestments`	$50.00M	USD	2 Qtrs
Other, net	`PaymentsForProceedsFromOtherInvestingActivities`	$-599.00M	USD	2 Qtrs
Other, net	`PaymentsForProceedsFromOtherInvestingActivities`	$-25.00M	USD	2 Qtrs
Cash flows from investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-1.46B	USD	2 Qtrs
Cash flows from investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-840.00M	USD	2 Qtrs
Proceeds from issuance of long-term debt	`ProceedsFromIssuanceOfLongTermDebt`	-	USD	2 Qtrs
Proceeds from issuance of long-term debt	`ProceedsFromIssuanceOfLongTermDebt`	$2.00B	USD	2 Qtrs
Repayments of long-term debt and finance lease obligations	`RepaymentsOfLongTermDebtAndCapitalSecurities`	$2.35B	USD	2 Qtrs
Repayments of long-term debt and finance lease obligations	`RepaymentsOfLongTermDebtAndCapitalSecurities`	$4.88B	USD	2 Qtrs
Dividends paid	`PaymentsOfDividends`	$5.29B	USD	2 Qtrs
Dividends paid	`PaymentsOfDividends`	$5.03B	USD	2 Qtrs
Purchases of treasury stock	`PaymentsForRepurchaseOfCommonStock`	$1.48B	USD	2 Qtrs
Purchases of treasury stock	`PaymentsForRepurchaseOfCommonStock`	$1.97B	USD	2 Qtrs
Proceeds from the exercise of stock options	`ProceedsFromStockOptionsExercised`	$113.00M	USD	2 Qtrs
Proceeds from the exercise of stock options	`ProceedsFromStockOptionsExercised`	$198.00M	USD	2 Qtrs
Payments of contingent consideration liabilities	`PaymentForContingentConsiderationLiabilityFinancingActivities`	$641.00M	USD	2 Qtrs
Payments of contingent consideration liabilities	`PaymentForContingentConsiderationLiabilityFinancingActivities`	$482.00M	USD	2 Qtrs
Other, net	`ProceedsFromPaymentsForOtherFinancingActivities`	$26.00M	USD	2 Qtrs
Other, net	`ProceedsFromPaymentsForOtherFinancingActivities`	$20.00M	USD	2 Qtrs
Cash flows from financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-9.65B	USD	2 Qtrs
Cash flows from financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-10.11B	USD	2 Qtrs
Effect of exchange rate changes on cash and equivalents	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$-2.00M	USD	2 Qtrs
Effect of exchange rate changes on cash and equivalents	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$-26.00M	USD	2 Qtrs
Net change in cash and equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-1.23B	USD	2 Qtrs
Net change in cash and equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-442.00M	USD	2 Qtrs
Cash and equivalents, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$8.52B	USD	Point-in-time
Cash and equivalents, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$9.20B	USD	Point-in-time
Cash and equivalents, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$8.76B	USD	Point-in-time
Cash and equivalents, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$9.75B	USD	Point-in-time
Cash and equivalents, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$8.52B	USD	Point-in-time
Cash and equivalents, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$9.20B	USD	Point-in-time
Cash and equivalents, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$8.76B	USD	Point-in-time
Cash and equivalents, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$9.75B	USD	Point-in-time

Stockholders Equity 36 line items

Line Item	Tag	Value	Unit	Period
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$15.44B	USD	Point-in-time
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$16.31B	USD	Point-in-time
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$12.90B	USD	Point-in-time
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$13.30B	USD	Point-in-time
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$14.69B	USD	Point-in-time
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$17.29B	USD	Point-in-time
Net earnings attributable to AbbVie Inc.	`NetIncomeLoss`	$2.26B	USD	2 Qtrs
Net earnings attributable to AbbVie Inc.	`NetIncomeLoss`	$5.41B	USD	2 Qtrs
Net earnings attributable to AbbVie Inc.	`NetIncomeLoss`	$924.00M	USD	1 Quarter
Net earnings attributable to AbbVie Inc.	`NetIncomeLoss`	$2.02B	USD	1 Quarter
Other comprehensive income (loss), net of tax	`OtherComprehensiveIncomeLossNetOfTax`	$-20.00M	USD	1 Quarter
Other comprehensive income (loss), net of tax	`OtherComprehensiveIncomeLossNetOfTax`	$-297.00M	USD	2 Qtrs
Other comprehensive income (loss), net of tax	`OtherComprehensiveIncomeLossNetOfTax`	$-53.00M	USD	2 Qtrs
Other comprehensive income (loss), net of tax	`OtherComprehensiveIncomeLossNetOfTax`	$-212.00M	USD	1 Quarter
Dividends declared	`DividendsCommonStockCash`	$5.26B	USD	2 Qtrs
Dividends declared	`DividendsCommonStockCash`	$2.51B	USD	1 Quarter
Dividends declared	`DividendsCommonStockCash`	$2.63B	USD	1 Quarter
Dividends declared	`DividendsCommonStockCash`	$5.03B	USD	2 Qtrs
Purchases of treasury stock	`TreasuryStockValueAcquiredCostMethod`	$1.97B	USD	2 Qtrs
Purchases of treasury stock	`TreasuryStockValueAcquiredCostMethod`	$1.48B	USD	2 Qtrs
Purchases of treasury stock	`TreasuryStockValueAcquiredCostMethod`	$10.00M	USD	1 Quarter
Purchases of treasury stock	`TreasuryStockValueAcquiredCostMethod`	$9.00M	USD	1 Quarter
Stock-based compensation plans and other	`StockIssuedDuringPeriodValueShareBasedCompensation`	$625.00M	USD	2 Qtrs
Stock-based compensation plans and other	`StockIssuedDuringPeriodValueShareBasedCompensation`	$178.00M	USD	1 Quarter
Stock-based compensation plans and other	`StockIssuedDuringPeriodValueShareBasedCompensation`	$226.00M	USD	1 Quarter
Stock-based compensation plans and other	`StockIssuedDuringPeriodValueShareBasedCompensation`	$632.00M	USD	2 Qtrs
Change in noncontrolling interest	`MinorityInterestPeriodIncreaseDecrease`	$7.00M	USD	2 Qtrs
Change in noncontrolling interest	`MinorityInterestPeriodIncreaseDecrease`	$3.00M	USD	1 Quarter
Change in noncontrolling interest	`MinorityInterestPeriodIncreaseDecrease`	$-1.00M	USD	2 Qtrs
Change in noncontrolling interest	`MinorityInterestPeriodIncreaseDecrease`	$4.00M	USD	1 Quarter
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$15.44B	USD	Point-in-time
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$16.31B	USD	Point-in-time
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$12.90B	USD	Point-in-time
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$13.30B	USD	Point-in-time
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$14.69B	USD	Point-in-time
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$17.29B	USD	Point-in-time

Comprehensive Income 52 line items

Line Item	Tag	Value	Unit	Period
Net earnings	`ProfitLoss`	$5.42B	USD	2 Qtrs
Net earnings	`ProfitLoss`	$2.27B	USD	2 Qtrs
Net earnings	`ProfitLoss`	$928.00M	USD	1 Quarter
Net earnings	`ProfitLoss`	$2.03B	USD	1 Quarter
Foreign currency translation adjustments, tax expense (benefit)	`OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax`	$-12.00M	USD	1 Quarter
Foreign currency translation adjustments, tax expense (benefit)	`OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax`	$-6.00M	USD	1 Quarter
Foreign currency translation adjustments, net of tax expense (benefit) of $(6) for the three months and $6 for the six months ended June 30, 2023 and $(12) for the three months and $(19) for the six months ended June 30, 2022	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax`	$-823.00M	USD	1 Quarter
Foreign currency translation adjustments, tax expense (benefit)	`OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax`	$-19.00M	USD	2 Qtrs
Foreign currency translation adjustments, net of tax expense (benefit) of $(6) for the three months and $6 for the six months ended June 30, 2023 and $(12) for the three months and $(19) for the six months ended June 30, 2022	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax`	$178.00M	USD	2 Qtrs
Foreign currency translation adjustments, net of tax expense (benefit) of $(6) for the three months and $6 for the six months ended June 30, 2023 and $(12) for the three months and $(19) for the six months ended June 30, 2022	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax`	$-16.00M	USD	1 Quarter
Foreign currency translation adjustments, net of tax expense (benefit) of $(6) for the three months and $6 for the six months ended June 30, 2023 and $(12) for the three months and $(19) for the six months ended June 30, 2022	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax`	$-1.05B	USD	2 Qtrs
Foreign currency translation adjustments, tax expense (benefit)	`OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax`	$6.00M	USD	2 Qtrs
Net investment hedging activities, tax expense (benefit)	`OtherComprehensiveIncomeLossNetInvestmentHedgeTax`	$-58.00M	USD	2 Qtrs
Net investment hedging activities, tax expense (benefit)	`OtherComprehensiveIncomeLossNetInvestmentHedgeTax`	$2.00M	USD	1 Quarter
Net investment hedging activities, net of tax expense (benefit) of $2 for the three months and $(58) for the six months ended June 30, 2023 and $146 for the three months and $183 for the six months ended June 30, 2022	`OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossAfterReclassificationandTax`	$-213.00M	USD	2 Qtrs
Net investment hedging activities, net of tax expense (benefit) of $2 for the three months and $(58) for the six months ended June 30, 2023 and $146 for the three months and $183 for the six months ended June 30, 2022	`OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossAfterReclassificationandTax`	$666.00M	USD	2 Qtrs
Net investment hedging activities, net of tax expense (benefit) of $2 for the three months and $(58) for the six months ended June 30, 2023 and $146 for the three months and $183 for the six months ended June 30, 2022	`OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossAfterReclassificationandTax`	$536.00M	USD	1 Quarter
Net investment hedging activities, tax expense (benefit)	`OtherComprehensiveIncomeLossNetInvestmentHedgeTax`	$146.00M	USD	1 Quarter
Net investment hedging activities, net of tax expense (benefit) of $2 for the three months and $(58) for the six months ended June 30, 2023 and $146 for the three months and $183 for the six months ended June 30, 2022	`OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossAfterReclassificationandTax`	$11.00M	USD	1 Quarter
Net investment hedging activities, tax expense (benefit)	`OtherComprehensiveIncomeLossNetInvestmentHedgeTax`	$183.00M	USD	2 Qtrs
Pension and post-employment benefits, net of tax expense (benefit) of $(4) for the three months and $10 for the six months ended June 30, 2023 and $11 for the three months and $21 for the six months ended June 30, 2022	`OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax`	$-76.00M	USD	2 Qtrs
Pension and post-employment benefits, net of tax expense (benefit) of $(4) for the three months and $10 for the six months ended June 30, 2023 and $11 for the three months and $21 for the six months ended June 30, 2022	`OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax`	$-36.00M	USD	2 Qtrs
Pension and post-employment benefits, tax expense (benefit)	`OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax`	$4.00M	USD	1 Quarter
Pension and post-employment benefits, tax expense (benefit)	`OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax`	$-11.00M	USD	1 Quarter
Pension and post-employment benefits, tax expense (benefit)	`OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax`	$-21.00M	USD	2 Qtrs
Pension and post-employment benefits, tax expense (benefit)	`OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax`	$-10.00M	USD	2 Qtrs
Pension and post-employment benefits, net of tax expense (benefit) of $(4) for the three months and $10 for the six months ended June 30, 2023 and $11 for the three months and $21 for the six months ended June 30, 2022	`OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax`	$-48.00M	USD	1 Quarter
Pension and post-employment benefits, net of tax expense (benefit) of $(4) for the three months and $10 for the six months ended June 30, 2023 and $11 for the three months and $21 for the six months ended June 30, 2022	`OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax`	$2.00M	USD	1 Quarter
Cash flow hedging activities, net of tax expense (benefit) of $(4) for the three months and $(8) for the six months ended June 30, 2023 and $5 for the three months and $3 for the six months ended June 30, 2022	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax`	$-54.00M	USD	2 Qtrs
Cash flow hedging activities, tax expense (benefit)	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax`	$3.00M	USD	2 Qtrs
Cash flow hedging activities, net of tax expense (benefit) of $(4) for the three months and $(8) for the six months ended June 30, 2023 and $5 for the three months and $3 for the six months ended June 30, 2022	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax`	$-13.00M	USD	1 Quarter
Cash flow hedging activities, tax expense (benefit)	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax`	$-8.00M	USD	2 Qtrs
Cash flow hedging activities, tax expense (benefit)	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax`	$5.00M	USD	1 Quarter
Cash flow hedging activities, net of tax expense (benefit) of $(4) for the three months and $(8) for the six months ended June 30, 2023 and $5 for the three months and $3 for the six months ended June 30, 2022	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax`	$27.00M	USD	1 Quarter
Cash flow hedging activities, net of tax expense (benefit) of $(4) for the three months and $(8) for the six months ended June 30, 2023 and $5 for the three months and $3 for the six months ended June 30, 2022	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax`	$15.00M	USD	2 Qtrs
Cash flow hedging activities, tax expense (benefit)	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax`	$-4.00M	USD	1 Quarter
Other comprehensive loss	`OtherComprehensiveIncomeLossNetOfTax`	$-20.00M	USD	1 Quarter
Other comprehensive loss	`OtherComprehensiveIncomeLossNetOfTax`	$-297.00M	USD	2 Qtrs
Other comprehensive loss	`OtherComprehensiveIncomeLossNetOfTax`	$-53.00M	USD	2 Qtrs
Other comprehensive loss	`OtherComprehensiveIncomeLossNetOfTax`	$-212.00M	USD	1 Quarter
Comprehensive income	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$2.21B	USD	2 Qtrs
Comprehensive income	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$716.00M	USD	1 Quarter
Comprehensive income	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$2.01B	USD	1 Quarter
Comprehensive income	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$5.12B	USD	2 Qtrs
Comprehensive income attributable to noncontrolling interest	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$7.00M	USD	2 Qtrs
Comprehensive income attributable to noncontrolling interest	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$3.00M	USD	1 Quarter
Comprehensive income attributable to noncontrolling interest	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$4.00M	USD	1 Quarter
Comprehensive income attributable to noncontrolling interest	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$5.00M	USD	2 Qtrs
Comprehensive income attributable to AbbVie Inc.	`ComprehensiveIncomeNetOfTax`	$5.12B	USD	2 Qtrs
Comprehensive income attributable to AbbVie Inc.	`ComprehensiveIncomeNetOfTax`	$712.00M	USD	1 Quarter
Comprehensive income attributable to AbbVie Inc.	`ComprehensiveIncomeNetOfTax`	$2.00B	USD	1 Quarter
Comprehensive income attributable to AbbVie Inc.	`ComprehensiveIncomeNetOfTax`	$2.21B	USD	2 Qtrs

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.